Use of sympathomimetic topical nasal decongestants to treat nasal obst
ruction is usually restricted to 3 to 5 days to avoid potential reboun
d swelling (rhinitis medicamentosa). In this study, 10 healthy volunte
ers used oxymetazoline (long-acting topical nasal decongestant) nightl
y for 4 weeks, Subjects who used antihistamines, oral or topical decon
gestants, or systemic steroids or who had active sinusitis were exclud
ed from the study, Weekly history, physical examination, and anterior
rhinomanometry revealed no adverse effects, Eight (80%) subjects devel
oped nightly nasal obstruction a few hours before the evening dose; th
e obstruction resolved within 48 hours if no more decongestant was use
d, All subjects remained responsive to oxymetazoline 4 weeks and 8 wee
ks after the study began, This finding suggests that long-acting decon
gestants may be safely used for longer than the recommended 3 to 5 day
s without adverse effects if used once nightly.